SAN DIEGO, CA--(Marketwire - October 02, 2007) - Althea Technologies, Inc. today announced the expansion of a collaboration with BiPar Sciences, Inc. to provide pharmacogenomic support for BiPar's drug development programs in oncology. Under terms of the agreement Althea Technologies will apply its innovative genomic technology and services to validate cancer biomarkers and predict clinical outcomes in BiPar's ongoing clinical trials.
